Hywel Madoc‐Jones - Concepedia

Author

Hywel Madoc‐Jones

Tufts Medical Center

Also Known As

H Madoc-Jones, H. MADOC-JONES, H. Madoc-Jones, H. Madoc‐Jones, Hywel Madoc-Jones, Hywel MadocJones, Hywel Madoc‐Jones

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Tufts Medical Center Mallinckrodt (United States)Washington University in St. Louis Royal Marsden Hospital Medical Center Hospital

About

Hywel Madoc‐Jones is an author at Tufts Medical Center specializing in medicine, radiation oncology, and radiation therapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	24	1.6K
2	Health Sciences	9	9	323
3	Public Health	3	3	378
4	Natural Sciences	2	2	165
5	Engineering	1	1	22

Hywel Madoc‐Jones

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications Carlos A. Perez, Sherry Breaux, John M. Bedwinek, Cancer Cervical Cancer ManagementCervical CancerRadiation TherapyMedicineBrachytherapy	1984	315
Radiation therapy alone in the treatment of carcinoma of uterine cervix I. Analysis of tumor recurrence Carlos A. Perez, Sherry Breaux, Hywel Madoc‐Jones, Cancer Cervical CancerRadiation TherapyMedicineTumor RecurrenceBrachytherapy	1983	239
Interphase action of vinblastine and vincristine: Differences in their lethal action through the mitotic cycle of cultured mammalian cells Hywel Madoc‐Jones, F. Mauro Journal of Cellular Physiology Abstract VinblastineMolecular BiologyCell DeathCellular PharmacologyCell Proliferation	1968	123
Variations in the generation times of a strain of rat sarcoma cells in culture K.B. Dawson, Hywel Madoc‐Jones, E.O. Field Experimental Cell Research Rat Sarcoma CellsCell DivisionPathologyCell CultureCell Proliferation	1965	112
Age responses of cultured mammalian cells to cytotoxic drugs. F. Mauro, Hywel Madoc‐Jones PubMed AgingCell DeathExponential DeclineCell CycleBiogerontology	1970	85
Prognostic factors for local and distant recurrence in Stage I and II cervical carcinoma Maria Werner‐Wasik, Christopher H. Schmid, Linda Bornstein, International Journal of Radiation OncologyBiologyPhysics Prognostic FactorsTumoral PathologyCervical CancerDistant RecurrenceCancer Recurrence	1995	76
Further follow-up of results of treatment in 90 laparotomy-negative stage I and II Hodgkin's disease patients: Significance of mediastinal and non-mediastinal presentations Lillian M. Fuller, Hywel Madoc‐Jones, Frederick Hagemeister, International Journal of Radiation OncologyBiologyPhysics Surgical PathologyPathologyIi HodgkinSurgeryDisease Patients	1980	66
Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia : Results of daily and intermittent fractionation with and without concomitant hydroxyurea Henry Wagner, Paul McKeough, Jane F. Desforges, Cancer Hematological MalignancySurgical OncologyRadiation TherapyMv PhotonsMedicine	1986	58
Correlation between radiation dose and tumor recurrence and complications in carcinoma of the uterine cervix: Stages I and IIA Carlos A. Pérez, Sherry Breaux, Hywel Madoc‐Jones, International Journal of Radiation OncologyBiologyPhysics Cervical CancerRadiation TherapyMedicineCancer RecurrenceTumor Recurrence	1979	51
New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and stage II patients Lillian M. Fuller, Hywel Madoc‐Jones, Jess F. Gamble, Cancer Stage Ii PresentationsDiagnosisPathologyPrognostic SignificanceSurgery	1977	51

Page 1